Beta blockers are indicated for management of acute coronary syndromes, but they generally are withheld in patients with cocaine-associated chest pain because of concerns for adverse outcomes related to the…
Current evidence supports deferral of revascularization for lesions with fractional flow reserve (FFR) values >0.80. The natural history after deferral of revascularization of lesions with borderline FFR values is unknown….
We explored trends in acute myocardial infarction (AMI) event rates in Norway during 1994 to 2009 and trends in the 6-month, 1-year, and 3-year risk of recurrences after an incident…
South Asians in the Western world have a high prevalence of diabetes mellitus (DM) and an increased risk of coronary artery disease (CAD) and mortality compared with Caucasians. CAD in…
Dr. Narula was born in Ajmer, India, on July 16, 1956. He graduated from Sawai Mansingh (SMS) Medical College in Jaipur, India, in 1978, where he also completed his training…
In ST-segment elevation myocardial infarction (STEMI), an effective antiplatelet treatment adjunctive to primary percutaneous coronary intervention is of utmost importance. High dose of clopidogrel, prasugrel, or ticagrelor provides a faster,…
Long-term exposure to ambient air pollution has been associated with cardiovascular morbidity and mortality. Impaired vascular responses may, in part, explain these findings, but the association of such long-term exposure…
I read the report by Migliorini et al. The report concludes “prasugrel is associated with increased inhibition of platelet aggregation and with a better clinical outcome than is clopidogrel.” I would…
The report by Harrison et al clinically informs the developmental events of Pfizer’s Björk-Shiley convexo-concave (BSCC) valve to date. I would like to present the other side of the story from…
We read the work by Shimony et al published in a recent issue of The American Journal of Cardiology . Their work is commendable and describes a novel risk predictor for…
